DSP Healthcare Fund Direct Growth

DSP Healthcare Fund Direct Growth

Equity
Sectoral
Very High Risk
+24.13%
3Y annualised
+0.88% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 27 Feb '26
₹42.40
Min. for SIP
₹100
Fund size
₹2,971.07 Cr
Expense ratio
0.65%

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
6 months₹30,000₹29,696
-1.01%
1 year₹60,000₹60,359
+0.60%
3 years₹1,80,000₹2,17,919
+21.07%
5 years₹3,00,000₹4,40,925
+46.98%

Holdings (31)

NameSectorInstrumentsAssets
Ipca Laboratories Ltd.HealthcareEquity8.40%
Sun Pharmaceutical Industries Ltd.HealthcareEquity8.25%
Cipla Ltd.HealthcareEquity8.08%
Globus Medical IncHealthcareForgn. Eq7.54%
Illumina Inc. (USA)HealthcareForgn. Eq7.18%
Laurus Labs Ltd.HealthcareEquity5.95%
Gland Pharma Ltd.HealthcareEquity5.72%
Sai Life Sciences Ltd.HealthcareEquity5.04%
Apollo Hospitals Enterprise Ltd.HealthcareEquity4.56%
Cohance Lifesciences Ltd.HealthcareEquity3.81%
Alembic Pharmaceuticals Ltd.HealthcareEquity3.76%
Pfizer Ltd.HealthcareEquity3.08%
Kovai Medical Center & Hospital Ltd.HealthcareEquity3.02%
Vijaya Diagnostic Centre Ltd.HealthcareEquity3.02%
Intuitive Surgical Inc. (USA)HealthcareForgn. Eq2.93%
Procter & Gamble Health Ltd.HealthcareEquity2.84%
Indoco Remedies Ltd.HealthcareEquity2.37%
Concord Biotech Ltd.HealthcareEquity1.94%
Emcure Pharmaceuticals Ltd.HealthcareEquity1.91%
ICICI Lombard General Insurance Company Ltd.InsuranceEquity1.47%
Nephrocare Health Services Ltd.HealthcareEquity1.13%
Aarti Drugs Ltd.HealthcareEquity1.09%
Abbott LaboratoriesHealthcareForgn. Eq1.07%
Unichem Laboratories Ltd.HealthcareEquity1.07%
Global X Genomics & Biotechnology ETFFinancialForeign MF0.90%
Alkem Laboratories Ltd.HealthcareEquity0.71%
CORONA Remedies Ltd.HealthcareEquity0.58%
Medplus Health Services Ltd.HealthcareEquity0.52%
Jupiter Life Line Hospitals Ltd.HealthcareEquity0.43%
Grail IncHealthcareForgn. Eq0.26%
Laxmi Dental Ltd.HealthcareEquity0.18%
See All

Minimum investments

Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+7.3%+24.1%+16.8%+22.1%
Category average (Equity Sectoral)-2.1%+22.1%+14.6%--
Rank (Equity Sectoral)21108--

Exit load, stamp duty and tax

Exit load

Exit load of 0.50% if redeemed within 1 month.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data

Fund management

CD
Chirag Dagli
Dec 2020 - Present
View details

Education
Mr. Dagli has done B. COM and Chartered Accountant.
Experience
Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.

About DSP Healthcare Fund Direct Growth

DSP Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by DSP Mutual Fund. This scheme was made available to investors on 16 Dec 1996. Chirag Dagli is the Current Fund Manager of DSP Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹2,22,551 Cr and the Latest NAV as of 27 Feb 2026 is ₹42.40. The DSP Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. Exit load of 0.50% if redeemed within 1 month. ;

Investment Objective

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#10 in India
Total AUM₹2,22,551.45 Cr
Date of Incorporation16 Dec 1996
Phone+91 22 6657 8000
E-mailNA
Launch Date16 Dec 1996
AddressThe Ruby, 25th Floor29, Senapati Bapat Marg,Dadar (West), Mumbai Mumbai 400028
CustodianCitibank NA
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,